Exploring new biological processes and causes of glaucoma
Uncovering novel biological processes and pathogenic mechanisms for glaucoma
This study is looking into the genes and biological processes that play a role in glaucoma, which could help us find new ways to treat this eye condition and improve vision for those affected.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts Eye and Ear Infirmary NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10845477 on NIH RePORTER |
What this research studies
This research investigates the genetic factors and biological processes that contribute to glaucoma, a leading cause of vision loss. By analyzing genomic regions and gene expression in eye tissues, the project aims to identify new genes and mechanisms involved in the disease. The approach combines large-scale genetic studies with advanced computational methods to uncover insights that could lead to novel therapies. Patients may benefit from improved understanding and potential new treatments for glaucoma.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with primary open angle glaucoma or those at risk for developing the condition.
Not a fit: Patients with other forms of glaucoma or those without a genetic predisposition to the disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic targets and improved treatment options for glaucoma patients.
How similar studies have performed: Previous research using genome-wide association studies has successfully identified genetic loci associated with glaucoma, indicating potential for success in this novel approach.
Where this research is happening
Boston, United States
- Massachusetts Eye and Ear Infirmary — Boston, United States (Active)
Researchers
- Principal investigator: Segre, Ayellet Vered — Massachusetts Eye and Ear Infirmary
- Study coordinator: Segre, Ayellet Vered
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.